P/E ratio for Adicet Bio (ACET)

P/E ratio history for Adicet Bio from 2020 to 2026

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Novartis NVS	21.4	-3,532.90%	🇨🇭 Switzerland
Pfizer PFE	37.5	-6,117.87%	🇺🇸 USA
Merck MRK	115	-18,513.17%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	62.9	-10,180.02%	🇮🇱 Israel
Hawkins HWKN	32.4	-5,294.31%	🇺🇸 USA
Quaker Houghton KWR	28.1	-4,601.61%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.